Lilly Stock Heading $1,000? What Investors Should Know
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Each age brings unique retirement planning needs. Discover what to do for retirement planning at different ages to ensure financial security.
16,672 articlesInvestors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Alphabet appears to be closing the gap with Nvidia in market value as AI-enabled services, search and cloud growth bo...
MercadoLibre has faced headwinds, but its long-term potential remains intact. Explore three strong reasons to conside...
The market looks frothy: moves are shaping how I protect gains without giving up long-term growth. Here are three con...
May brings renewed focus on national security and market resilience. This guide identifies a top defense stock and sh...
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
As investors seek clarity in a shifting media world, Newsmax’s Q1 2026 earnings offer clues about growth, profitabili...
Warren Buffett famously bailed on airlines in 2020. Now Berkshire Hathaway backs Delta with a multi-billion stake, si...
Investors are watching a niche player circle the AI data-center space. This small crypto miner is shifting gears, spa...
Four giants could join the exclusive $3 trillion club by 2027. This article breaks down the drivers, the risks, and h...
Is SpaceX heading to the stock market? This article breaks down the IPO question with insights inspired by Jim Cramer...
Bitcoin slides below key price floors as traders brace for a new Fed Chair and policy shifts. The week saw mixed acti...